These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21917055)

  • 1. Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype.
    Alvero AB; Montagna MK; Craveiro V; Liu L; Mor G
    Am J Reprod Immunol; 2012 Mar; 67(3):256-65. PubMed ID: 21917055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
    Zhu Q; Wu X; Wu Y; Wang X
    Oncol Rep; 2016 Dec; 36(6):3472-3478. PubMed ID: 27748885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast activation proteins-α suppress tumor immunity by regulating T cells and tumor-associated macrophages.
    Hou CM; Qu XM; Zhang J; Ding TT; Han W; Ji GC; Zhong ZH; Chen H; Zhang F
    Exp Mol Pathol; 2018 Feb; 104(1):29-37. PubMed ID: 29273462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.
    Khan AN; Kolomeyevskaya N; Singel KL; Grimm MJ; Moysich KB; Daudi S; Grzankowski KS; Lele S; Ylagan L; Webster GA; Abrams SI; Odunsi K; Segal BH
    Oncotarget; 2015 May; 6(13):11310-26. PubMed ID: 25888637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells.
    Surówka J; Wertel I; Okła K; Bednarek W; Tarkowski R; Kotarski J
    Clin Transl Oncol; 2017 Dec; 19(12):1489-1497. PubMed ID: 28589429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer.
    Zhou J; Li X; Wu X; Zhang T; Zhu Q; Wang X; Wang H; Wang K; Lin Y; Wang X
    Cancer Immunol Res; 2018 Dec; 6(12):1578-1592. PubMed ID: 30396909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Killer Cells Response to IL-2 Stimulation Is Distinct between Ascites with the Presence or Absence of Malignant Cells in Ovarian Cancer Patients.
    da Silva RF; Yoshida A; Cardozo DM; Jales RM; Paust S; Derchain S; Guimarães F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response evaluation through determination of type 1, type 2, and type 17 patterns in patients with epithelial ovarian cancer.
    Cândido EB; Silva LM; Carvalho AT; Lamaita RM; Filho RM; Cota BD; da Silva-Filho AL
    Reprod Sci; 2013 Jul; 20(7):828-37. PubMed ID: 23239818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer.
    Chen Y; Zhang L; Lv R; Zhang WQ
    Asian Pac J Cancer Prev; 2013; 14(10):5883-90. PubMed ID: 24289594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients.
    Nowak M; Głowacka E; Lewkowicz P; Banasik M; Szyłło K; Zimna K; Bednarska K; Klink M
    Immunobiology; 2018 Jan; 223(1):1-7. PubMed ID: 29017822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.
    Nishio H; Yaguchi T; Sugiyama J; Sumimoto H; Umezawa K; Iwata T; Susumu N; Fujii T; Kawamura N; Kobayashi A; Park J; Aoki D; Kawakami Y
    Br J Cancer; 2014 Jun; 110(12):2965-74. PubMed ID: 24867687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization.
    Chen X; Ying X; Wang X; Wu X; Zhu Q; Wang X
    Oncol Rep; 2017 Jul; 38(1):522-528. PubMed ID: 28586039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer: A Brief Report.
    Cannioto RA; Sucheston-Campbell LE; Hampras S; Goode EL; Knutson K; Ness R; Modugno F; Wallace P; Szender JB; Mayor P; Hong CC; Joseph JM; Friel G; Davis W; Nesline M; Eng KH; Edwards RP; Kruszka B; Schmitt K; Odunsi K; Moysich KB
    Int J Gynecol Cancer; 2017 Jan; 27(1):11-16. PubMed ID: 27759594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.
    Webb JR; Milne K; Kroeger DR; Nelson BH
    Gynecol Oncol; 2016 May; 141(2):293-302. PubMed ID: 26972336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization.
    Xie X; He J; Wang Q; Liu Y; Chen W; Shi K
    J Ovarian Res; 2021 Dec; 14(1):177. PubMed ID: 34930387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
    Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
    Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two microRNA signatures for malignancy and immune infiltration predict overall survival in advanced epithelial ovarian cancer.
    Korsunsky I; Parameswaran J; Shapira I; Lovecchio J; Menzin A; Whyte J; Dos Santos L; Liang S; Bhuiya T; Keogh M; Khalili H; Pond C; Liew A; Shih A; Gregersen PK; Lee AT
    J Investig Med; 2017 Oct; 65(7):1068-1076. PubMed ID: 28716985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance.
    Winkler I; Wilczynska B; Bojarska-Junak A; Gogacz M; Adamiak A; Postawski K; Darmochwal-Kolarz D; Rechberger T; Tabarkiewicz J
    J Ovarian Res; 2015 Jun; 8():39. PubMed ID: 26077607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immune inhibitory cytokine profiles in epithelial ovarian carcinoma.
    Chen LL; Ye F; Lü WG; Yu Y; Chen HZ; Xie X
    J Obstet Gynaecol Res; 2009 Apr; 35(2):212-8. PubMed ID: 19335794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FoxP3+ regulatory T cells in peripheral blood of patients with epithelial ovarian cancer.
    Erfani N; Hamedi-Shahraki M; Rezaeifard S; Haghshenas M; Rasouli M; Samsami Dehaghani A
    Iran J Immunol; 2014 Jun; 11(2):105-12. PubMed ID: 24975967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.